查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1293911

血管栓塞市場：按栓塞技術（捲繞裝置、非捲繞裝置）、按應用（神經學、腫瘤學、周圍血管疾病）、最終用戶 - 俄羅斯-烏克蘭衝突和高通脹 - 2023-2030 年全球預測

Vascular Embolization Market by Embolization Technique (Coiling Devices, Non-Coiling Devices), Application (Neurology, Oncology, Peripheral Vascular Disease), End-User - Russia Ukraine Conflict and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2023 年，全球血管栓塞市場將達到 20.9671 億美元，複合年增長率為 11.31%，預計到 2030 年將出現驚人增長，達到 44.5897 億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球血管栓塞市場至關重要。 通過檢查業務戰略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的具體需求做出明智的決策。 這種高級分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市場份額分析

市場份額分析可以深入了解供應商在特定市場區域的當前狀態。 比較供應商對整體收入、客戶群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場份額時的表現以及面臨的情況。 該分析還揭示了特定行業的競爭程度、積累和分散的優勢以及研究基準年的併購特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要公司所服務的市場的全面信息。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細信息，並分析其在成熟市場領域的滲透率。

3. 市場多元化：提供有關新產品發布、未開發地區、最新開發和投資的詳細信息。

4. 市場趨勢：全面了解 COVID-19、俄羅斯-烏克蘭衝突和高通脹的累積影響。

5.競爭評估與信息：對各大公司的市場份額、戰略、產品、認證、監管狀況、專利狀況、製造能力進行綜合評估。

6. 產品開發和創新：提供對未來技術、研發活動和突破性產品開發的見解。

此報告回答了以下問題：

1.全球血管栓塞市場規模及預測是多少？

2. 在預測期內，COVID-19 對全球血管栓塞市場的抑制因素和影響有哪些？

3.在預測期內，全球血管栓塞市場需要投資哪些產品/細分市場/應用/領域？

4.你們在全球血管栓塞市場的競爭策略是什麼？

5.全球血管栓塞市場的技術趨勢和監管框架是什麼？

6.全球血管栓塞市場主要廠商的市場份額是多少？

7.什麼形式和戰略舉措被認為適合進入全球血管栓塞市場？

目錄

第1章前言

第2章研究方法

第 3 章執行摘要

第4章市場概述

第 5 章市場洞察

  • 市場動態
    • 促進因素
      • 血管疾病患病率不斷上升
      • 對微創手術的偏好日益增加
      • 栓塞產品和技術的開發
    • 抑制因素
      • 與栓塞相關的高成本
    • 機會
      • 血管栓塞生物材料和技術的進展
    • 作業
      • 與栓塞相關的並發症
  • 市場趨勢
  • 新冠肺炎 (COVID-19) 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通脹的累積影響
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 監管框架
  • 客戶定制

第6章按栓塞技術劃分的血管栓塞市場

  • 捲取裝置
  • 非捲取裝置

第7章血管栓塞市場：按應用

  • 神經病學
  • 腫瘤學
  • 周圍血管疾病
  • 泌尿科

第 8 章血管栓塞市場：按最終用戶劃分

  • 門診手術中心
  • 診斷中心
  • 醫院
  • 專科診所

第9章北美和南美血管栓塞市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區血管栓塞市場

  • 澳大利亞
  • 中國
  • 印度
  • 印度尼西亞
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲血管栓塞市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 意大利
  • 荷蘭
  • 尼日利亞
  • 挪威
  • 波蘭
  • 卡塔爾
  • 俄羅斯
  • 沙特阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合酋長國
  • 英國

第12章競爭態勢

  • FPNV定位矩陣
  • 市場份額分析：按主要公司劃分
  • 競爭情景分析：主要公司

第13章上市公司名單

第14章附錄

  • 討論指南
  • 關於許可證和價格
Product Code: MRR-742BD5184D6E

The Global Vascular Embolization Market is forecasted to grow significantly, with a projected USD 2,096.71 million in 2023 at a CAGR of 11.31% and expected to reach a staggering USD 4,458.97 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Vascular Embolization Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Vascular Embolization Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Embolization Technique, market is studied across Coiling Devices and Non-Coiling Devices. The Non-Coiling Devices is projected to witness significant market share during forecast period.

Based on Application, market is studied across Neurology, Oncology, Peripheral Vascular Disease, and Urology. The Neurology is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Ambulatory Surgical Centers, Diagnostics Centers, Hospitals, and Specialty Clinics. The Ambulatory Surgical Centers is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Vascular Embolization Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Vascular Embolization Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Vascular Embolization Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Vascular Embolization Market?

4. What is the competitive strategic window for opportunities in the Global Vascular Embolization Market?

5. What are the technology trends and regulatory frameworks in the Global Vascular Embolization Market?

6. What is the market share of the leading vendors in the Global Vascular Embolization Market?

7. What modes and strategic moves are considered suitable for entering the Global Vascular Embolization Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Vascular Embolization Market, by Embolization Technique, 2022 vs 2030
  • 4.3. Vascular Embolization Market, by Application, 2022 vs 2030
  • 4.4. Vascular Embolization Market, by End-User, 2022 vs 2030
  • 4.5. Vascular Embolization Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of vascular diseases
      • 5.1.1.2. Increasing preference for minimally invasive procedures
      • 5.1.1.3. Development in embolization products and procedures
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with embolization procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Advances in biomaterials and technologies for vascular embolization
    • 5.1.4. Challenges
      • 5.1.4.1. Complications associated with embolization procedures
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Vascular Embolization Market, by Embolization Technique

  • 6.1. Introduction
  • 6.2. Coiling Devices
  • 6.3. Non-Coiling Devices

7. Vascular Embolization Market, by Application

  • 7.1. Introduction
  • 7.2. Neurology
  • 7.3. Oncology
  • 7.4. Peripheral Vascular Disease
  • 7.5. Urology

8. Vascular Embolization Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Diagnostics Centers
  • 8.4. Hospitals
  • 8.5. Specialty Clinics

9. Americas Vascular Embolization Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Vascular Embolization Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Vascular Embolization Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

1. Abbott Laboratories

2. B. Braun Melsungen AG

3. Becton, Dickinson and Company

4. Boston Scientific Corporation

5. Cook Medical Inc.

6. Kaneka Corporation

7. Lepu Medical Technology Co.,Ltd.

8. Medtronic PLC

9. Merit Medical Systems Inc.

10. Penumbra Inc

11. Shape Memory Medical Inc.

12. Stryker Corporation

13. Terumo Corporation

14. W. L. Gore & Associates Inc.

15. WEGO Healthcare Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. VASCULAR EMBOLIZATION MARKET RESEARCH PROCESS
  • FIGURE 2. VASCULAR EMBOLIZATION MARKET SIZE, 2022 VS 2030
  • FIGURE 3. VASCULAR EMBOLIZATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2022 VS 2030 (%)
  • FIGURE 5. VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 6. VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 7. VASCULAR EMBOLIZATION MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. VASCULAR EMBOLIZATION MARKET DYNAMICS
  • FIGURE 9. VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. VASCULAR EMBOLIZATION MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. VASCULAR EMBOLIZATION MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. VASCULAR EMBOLIZATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. VASCULAR EMBOLIZATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 5. VASCULAR EMBOLIZATION MARKET SIZE, BY COILING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. VASCULAR EMBOLIZATION MARKET SIZE, BY NON-COILING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 8. VASCULAR EMBOLIZATION MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. VASCULAR EMBOLIZATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. VASCULAR EMBOLIZATION MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. VASCULAR EMBOLIZATION MARKET SIZE, BY UROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 13. VASCULAR EMBOLIZATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. VASCULAR EMBOLIZATION MARKET SIZE, BY DIAGNOSTICS CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. VASCULAR EMBOLIZATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. VASCULAR EMBOLIZATION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM VASCULAR EMBOLIZATION MARKET SIZE, BY EMBOLIZATION TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM VASCULAR EMBOLIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM VASCULAR EMBOLIZATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. VASCULAR EMBOLIZATION MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 145. VASCULAR EMBOLIZATION MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 146. VASCULAR EMBOLIZATION MARKET LICENSE & PRICING